| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net income (loss) | ||||||||
-8,555 | -4,300 | -22,695 | -23,014 | -25,738 | -27,651 | 0 | 0 | 0 |
Adjustments to reconcile from net income (loss) to net cash used in operating activities: | ||||||||
Depreciation | ||||||||
274 | 225 | 185 | 160 | 126 | 120 | 0 | 0 | 0 |
Amortization of debt discount and debt issuance cost | ||||||||
0 | - | - | - | - | 5,278 | 0 | 0 | 0 |
Change in fair value of warrant derivative | ||||||||
- | 5,251 | 0 | 0 | 0 | - | - | - | - |
Stock-based compensation expense | ||||||||
327 | 336 | 175 | 710 | 634 | 557 | 0 | 0 | 0 |
Changes in operating assets and liabilities | ||||||||
Accounts receivable | ||||||||
-268 | 1,089 | 695 | 465 | 1,191 | 832 | 0 | 0 | 0 |
Factor receivables, net | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Factor receivables, net | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Inventory | ||||||||
119 | 1,835 | 1,729 | 1,038 | 1,431 | 281 | 0 | 0 | 0 |
(Increase) decrease in prepaid assets | ||||||||
- | - | - | - | - | - | - | - | 0 |
Prepaid assets | ||||||||
-190 | 32 | 0 | 0 | 0 | - | - | - | - |
Other assets | ||||||||
0 | - | - | - | - | - | - | - | - |
Decrease in security deposits | ||||||||
- | - | - | - | - | - | - | - | 0 |
Accounts payable | ||||||||
-371 | 573 | -1,668 | -1,353 | -806 | -368 | 0 | 0 | 0 |
Accrued payroll taxes | ||||||||
- | - | - | - | 0 | - | - | - | - |
Accrued expenses | ||||||||
0 | - | - | - | - | - | - | - | - |
Other current liabilities | ||||||||
- | - | - | - | 0 | - | - | - | 0 |
Accrued liabilities | ||||||||
- | - | - | 0 | 0 | - | 0 | 0 | 0 |
(Decrease) increase in accrued payroll taxes | ||||||||
- | - | - | - | - | - | - | - | 0 |
Net cash used in operating activities | ||||||||
-9,275 | -10,229 | -14,963 | -13,043 | -12,201 | -8,243 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | ||||||||
1,074 | 1,031 | 0 | 0 | 0 | - | - | - | - |
Net cash used in investing activities | ||||||||
-1,074 | -1,031 | 0 | 0 | 0 | - | - | - | - |
Cash flows from financing activities: | ||||||||
Proceeds from sales of common stock and warrants, net of costs | ||||||||
0 | - | - | - | - | - | - | - | - |
Proceeds from exercise of Series A warrants | ||||||||
- | 2,172 | 0 | 0 | 0 | - | - | - | - |
Proceeds from exercise of Placement Agent warrants | ||||||||
- | - | - | - | 0 | - | - | - | - |
Proceeds from sale of convertible preferred stock, net of costs | ||||||||
- | - | - | - | - | 1,201 | 0 | 0 | 0 |
Cash payment for debt modification | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Cash proceeds (payments) from loans payable | ||||||||
- | - | - | - | 0 | - | - | - | - |
Proceeds from factor loan payable | ||||||||
0 | - | - | - | - | - | - | - | - |
Repayments of Series D Preferred Stock | ||||||||
0 | - | - | - | - | - | - | - | - |
Cash (payments of) proceeds from loans payable | ||||||||
- | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | ||||||||
10,581 | 5,825 | 18,011 | 14,292 | 14,755 | 13,658 | 0 | 0 | 0 |
Net increase (decrease) in cash | ||||||||
231 | -5,434 | 0 | 0 | 0 | - | - | - | - |
Net decrease in cash | ||||||||
- | - | - | - | - | - | - | - | 0 |
Supplemental disclosure of non-cash investing and financing activities: | ||||||||
Cashless exercise of warrants | ||||||||
0 | - | - | - | - | - | - | - | - |
Conversion of Series B warrants into common stock | ||||||||
- | - | - | - | 0 | - | - | - | - |
Conversion of Series C Preferred Stock to common stock | ||||||||
0 | - | - | - | - | - | - | - | - |
Conversion of convertible notes payable to common stock | ||||||||
0 | - | - | - | - | - | - | - | - |
Issuance of warrants as compensation for capital raise | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Issuance of convertible preferred stock as debt issuance cost | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |